Mortgage broker London & Country weighs up £300m sale or IPO
London & Country Mortgages (L&C), the city-based mortgage advisor, is weighing up a potential sale or initial public offering (IPO) that could see its value placed in the nine figures.
The firm has appointed Fenchurch Advisory Partners to run a twin-track sales process that will see it offered to rival brokers, banks, independent financial advisors and comparison websites.
While an L&C spokesperson would not comment on the value of a sale or float on the London Stock Exchange, The Telegraph has reported that it could be valued at up to £300m.
The spokesperson said: “L&C confirms that, following receipt of certain expressions of interest, it has appointed Fenchurch to advise on a range of strategic options for the business including a potential sale or initial public offering.
“There is no certainty that this review will lead to a transaction and L&C will also consider the benefits of continued growth of the business under its current ownership.”
Last year the firm, which also has offices in Newcastle and Bath, reported a pre-tax profit of £8.5m and a £35.2m revenue.
Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →
Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular morning London email for free.
Improving North East transport will improve lives
Unlocking investment potential before year end
Give us certainty to deliver better homes
Hormuz: Safe passage - not insurance - the issue
Don't get caught out by employment law change
When literacy thrives, our businesses thrive too
Building a more diverse construction sector
The value of using data like a Premier League club
Raising the bar to boost North East growth
Navigating the messy middle of business growth
We must make it easier to hire young people
Why community-based care is key to NHS' future